FDA & Regulatory
Breakthrough Therapy Designation
Breakthrough Therapy Designation (BTD) is an FDA program for drugs treating serious conditions where early evidence shows substantial improvement over existing options. It grants intensive FDA guidance and eligibility for faster review pathways.
- Category
- FDA & Regulatory
- Abbreviation
- BTD
Prepared research question
How does Breakthrough Therapy Designation affect the view of a biotech company in practice?
Traceable citations · Unknowns marked
Breakthrough Therapy Designation (BTD) is an FDA program for drugs treating serious conditions where early evidence shows substantial improvement over existing options. It grants intensive FDA guidance and eligibility for faster review pathways.
Related terms
Learn more
From term to thesis rule
Investigate how Breakthrough Therapy Designation changes a biotech thesis
Define when Breakthrough Therapy Designation should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.